Demo

Marking a breakthrough in blood pressure monitoring, OMRON Healthcare—a leader in heart health—today unveiled home blood pressure monitors equipped with AI-powered atrial fibrillation (AFib) detection. In a first for medical devices, these monitors feature OMRON’s proprietary IntelliSense AFib algorithm, which uses machine learning to automatically screen for AFib during each reading. This advancement enables early detection of a condition linked to increased risks of stroke¹ and heart failure².

“OMRON Healthcare is evolving the blood pressure monitoring experience by making AFib screening an integral part of every measurement. AFib is a serious condition that is widely undiagnosed. With Intellisense AFib, we are working to help anyone who uses our blood pressure monitors detect this condition earlier so they can reduce the associated stroke, heart failure and dementia risks,” said OMRON Healthcare U.S. Managing Director Alice Koehler.

OMRON blood pressure monitors with Intellisense AFib are compatible with the OMRON Connect app and clinical accurate.

OMRON Platinum BP5465: Featuring a backlit dual display and storage for 200 readings for two users (100 readings each user), OMRON Platinum is ranked by The New York Times Wirecutter as the overall “best blood pressure monitor for home use”.

OMRON 10 Series BP7465: This OMRON best-seller features a large, backlit display with TruRead technology, stores 200 readings for two users (100 readings each user), and is recommended by Consumer Reports for its accuracy and ease of use.

OMRON 7 Series BP7360: With a large, easy-to-read display, this compact monitor stores 120 readings for two users (60 readings each user) and is rated by Health & Living as one of the Best Blood Pressure Monitors of 2025.

OMRON Gold BP5360: A favorite for its sleek design and bright display, this monitor stores 160 readings (80 readings per user) and is highly rated as a “premium option” by BPM Reviews for its exceptional accuracy and ease-of-use.

“Our blood pressure monitors with Intellisense AFib automatically screen for atrial fibrillation with every single measurement,” said Koehler. “With this breakthrough AFib detection, OMRON is setting a new high standard for the blood pressure monitoring experience.”

AFib is the most common type of heart arrythmia3. Left untreated, the condition increases risk of stroke, heart failure, myocardial infarction, chronic kidney disease, and dementia4.

AFib risk factors accelerate over age 40 and include high blood pressure, obesity, diabetes, smoking, heavy use of alcohol, and sleep apnea5.

Medical experts say AFib has become a health epidemic6. A study published in the September 2024 Journal of the American College of Cardiology7 found that AFib is three times more prevalent than previously estimated. The American Stroke Association estimates that millions of Americans with AFib are undiagnosed8 and many may not experience symptoms9.

OMRON IntelliSense AFib incorporates over 300 mathematical indices into a machine learning algorithm that analyzes the Pressure Pulse Wave generated as the blood pressure monitor cuff inflates. A clinical study published in the October 2024 Heart Rhythm Journal10 found that OMRON blood pressure monitors with Intellisense AFib can detect disturbances specific to AFib with remarkable accuracy.

The FDA granted OMRON Healthcare medical-device authorization for Intellisense AFib via the agency’s De Novo classification11, a regulatory pathway for first-of-their-kind innovations.12

With the launch of blood pressure monitors with Intellisense AFib, OMRON introduced an AFib education hub that explains the condition, its risk factors, and common symptoms. OMRON’s AFib education hub provides details on how Intellisense AFib works and how OMRON developed the innovation as part of its Going for Zero mission.

AFib education extends to the OMRON Connect app, which syncs with every Intellisense AFib blood pressure monitor via Bluetooth to iOS and Android devices. OMRON Connect charts user readings by the day, week, month and year. The app analyzes a user’s trends and habits, presents insights to explain data, and provides daily reminders and progress reports. With OMRON Connect, a user can send heart health readings to a doctor.

“Research shows ninety percent of heart attacks and strokes are preventable13. By evolving the blood pressure monitoring experience with Intellisense AFib, OMRON is providing unprecedented at-home access to technologies that can make a world of difference in heart health,” said Koehler.

1 CDC AFib and Stroke https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html?CDC_AAref_Val=https://www.cdc.gov/heartdisease/atrial_fibrillation.htm

2 AFib and Heart Failure https://www.hopkinsmedicine.org/health/conditions-and-diseases/atrial-fibrillation/afib-complications

3 CDC About Atrial Fibrillation https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html?CDC_AAref_Val=https://www.cdc.gov/heartdisease/atrial_fibrillation.htm

4 AFib and Dementia Risk https://pmc.ncbi.nlm.nih.gov/articles/PMC10568548/

5 NIH https://pmc.ncbi.nlm.nih.gov/articles/PMC8158444/

6 AHAIASA Journals https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.316340

7 JACC study https://medconnection.ucsfhealth.org/news/how-many-people-have-a-fib-three-times-more-than-we-thought

8 American Stroke Association https://scnow.com/news/health/many-people-have-atrial-fibrillation-but-may-not-know-it/article_bb910f20-cc44-11e9-8406-c39ac04db63b.html

9 Cleveland Clinic https://health.clevelandclinic.org/atrial-fibrillation-dispelling-6-myths

10 Heart Rhythm Journal, October 2024 https://www.heartrhythmjournal.com/article/S1547-5271(24)02520-7/fulltext

11 FDA De Novo https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/de-novo-classification-request

12 FDA De Novo AI First https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-device-uses-artificial-intelligence-help-detect-potential-signs-colon

13 Cleveland Clinic https://newsroom.clevelandclinic.org/2021/09/29/90-percent-of-heart-disease-is-preventable-through-healthier-diet-regular-exercise-and-not-smoking

Leave A Reply

WebNewsAddiction.com is a dynamic platform dedicated to delivering in-depth opinions, interviews, stories, including coverage of news and key events cutting across a slew of sectors for the new-age audience. Our website serves as your one-stop destination for reliable and insightful content. Stay informed with the latest trends and expert insights, all in one place.

Categories

Copyright 2025, All rights reserved WEBNEWSADDICTION